Join
Live feed
·
INSIDERFilingvia Quantisnow
RAPT Therapeutics Inc. logo

Director Braunstein Scott was granted 4,956 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RAPT· RAPT Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RAPT (RAPT Therapeutics Inc.) and more on Quantisnow.

Director Braunstein Scott was granted 4,956 shares (SEC Form 4) | Quantisnow